Trademark Search in Canada

ACADIA

View On IC.GC.CA

REGISTERED

on 24 Nov 2023

Last Applicant/ Owned by

ACADIA PHARMACEUTICALS INC.

12830 El Camino Real, Suite 400San Diego CA 92130

Serial Number

2116192 filed on 26^th Jan 2021

Registration Number

TMA1210757 registered on 24^th Nov 2023

Registration expiry Date

26^th Jan 2031

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

SUITE 6200, P.O. BOX 501 FIRST CANADIAN PLACETORONTO

ONTARIO

M5X1B8

ACADIA

Trademark usage description

pharmaceuticals for use in the prevention and treatment of neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders, namely Read More

Vienna Information

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

Classification Information

Class [005]
Pharmaceuticals for use in the prevention and treatment of neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders, namely Parkinson's disease, Alzheimer's disease, schizophrenia, chronic pain and glaucoma

Classification kind code

Class [042]
Scientific research in the field of neurologic, metabolic and genetic diseases and disorders; industrial biotechnological and biomedical research; chemical, biochemical and molecular biological analyses; in vitro and in vivo preclinical testing of potential drugs; medical consulting with respect to neurologic, metabolic, and genetic conditions and their treatment

Classification kind code

Mark Details

Serial Number

2116192

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 135 on 7^th Jul 2022	Amendment to Application
Submitted for opposition 256 on 25^th Apr 2022	Notification of Possible Opposition Sent
Submitted for opposition 48 on 17^th Dec 2021	Agent Changed
Submitted for opposition 257 on 11^th Nov 2021	Designation Notification - Madrid Protocol
Submitted for opposition 257 on 24^th Jun 2021	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 23^rd Jun 2021	Created
Submitted for opposition 31 on 23^rd Jun 2021	Formalized
Submitted for opposition 30 on 26^th Jan 2021	Filed
Submitted for opposition 210 on 26^th Jan 2021	IR Correction
Submitted for opposition 228 on 26^th Jan 2021	International Registration

ACADIA

Classification Information

Class [005]Pharmaceuticals for use in the prevention and treatment of neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders, namely Parkinson's disease, Alzheimer's disease, schizophrenia, chronic pain and glaucoma

Classification kind code

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceuticals for use in the prevention and treatment of neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders, namely Parkinson's disease, Alzheimer's disease, schizophrenia, chronic pain and glaucoma